HIF1A and familial pancreatic carcinoma: Although the positive correlations between HIF-1α expression levels as well as the volume of hypoxic regions and both the poor prognosis of pancreatic cancer patients [9, 10] and decreased anti-tumor effects of HIF-1α-targeting drugs in pancreatic tumors [14, 15] have been repeatedly reported, key molecular mechanisms behind them are still unclear.